Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.

Thrombosis and haemostasis - 1 Apr 2014

Konieczynska Malgorzata, Fil Korneliusz, Bazanek Marta, Undas Anetta

Abstract excerpt

It has been shown that type 2 diabetes (DM) is associated with enhanced thrombin generation and formation of denser fibrin clots of reduced lysability. We sought to investigate the impact of diabetes duration versus glycaemia control on fibrin clot phenotype and its determinants in type 2 diabetic patients. In 156 consecutive Caucasian patients with type 2 diabetes we investigated ex vivo thrombin generation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Fibrin

Share to Fibrin Fibrinogen Degradation Products

Share to Fibrinolysis

Share to Plasminogen Activator Inhibitor 1

Share to Thrombin

Source

Identifiers

PMID: 24306139
DOI: 10.1160/TH13-07-0566

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.PMID 24306139Read ↗

BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.Semantic proximity Read ↗

Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.Semantic proximity Read ↗

Maturity onset diabetes of the young and fibrin-related thrombosis risk.Semantic proximity Read ↗

Hematological and Hemorheological Parameters of Blood Platelets as Biomarkers in Diabetes Mellitus Type 2. A Comprehensive ReviewSemantic proximity Read ↗

Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease.Semantic proximity Read ↗

Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.Semantic proximity Read ↗

Possible association between haemostasis dysfunction and early onset of microvascular complications in patients with type 1 diabetes.Semantic proximity Read ↗

Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus.Semantic proximity Read ↗

Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy.Semantic proximity Read ↗

Hypofibrinolytic phenotype in Tsumura Suzuki Obese Diabetes (TSOD) mice unrelated to hyperglycemia.Semantic proximity Read ↗

Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls.Semantic proximity Read ↗

Altered fibrin clot properties in patients with premature peripheral artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.